Table 1 Demographic and clinicopathologic characteristics of colorectal cancer cases according to T cell proximity score.

From: Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer

  

T cell proximity score

Characteristic

Total N

Low

Intermediate

High

P

All cases

983 (100%)

194 (20%)

545 (55%)

244 (25%)

 

Sex

    

0.65

 Female

481 (49%)

96 (49%)

260 (48%)

125 (51%)

 

 Male

502 (51%)

98 (51%)

285 (52%)

119 (49%)

 

Age (years)

    

0.17

 <65

265 (27%)

57 (29%)

142 (26%)

66 (27%)

 

 65–75

348 (35%)

58 (30%)

211 (39%)

79 (32%)

 

 >75

370 (38%)

79 (41%)

192 (35%)

99 (41%)

 

Year of operation

    

0.26

 2000–2005

299 (30%)

60 (31%)

153 (28%)

86 (35%)

 

 2006–2010

315 (32%)

65 (34%)

183 (34%)

67 (28%)

 

 2011–2015

369 38%)

69 (36%)

209 (38%)

91 (37%)

 

Tumour location

    

0.0003

 Proximal colon

478 (49%)

82 (42%)

249 (46%)

147 (60%)

 

 Distal colon

359 (40%)

83 (43%)

214 (39%)

62 (25%)

 

 Rectum

146 (15%)

29 (15%)

82 (15%)

35 (14 %)

 

AJCC disease stage

    

<0.0001

 I

162 (16%)

19 (10%)

84 (15%)

59 (24%)

 

 II

371 (38%)

62 (32%)

193 (35%)

116 (48%)

 

 III

322 (33%)

80 (41%)

186 (34%)

56 (23%)

 

 IV

128 (13%)

33 (17%)

82 (15%)

13 (5.3%)

 

Tumour grade

    

0.061

 Low-grade (well to moderately differentiated)

813 (83%)

166 (86%)

457 (84%)

190 (78%)

 

 High-grade (poorly differentiated)

170 (17%)

28 (14%)

88 (16%)

54 (22%)

 

Lymphovascular invasion

    

<0.0001

 No

772 (79%)

132 (68%)

423 (78%)

217 (89%)

 

 Yes

211 (21%)

62 (32%)

122 (22%)

17 (11%)

 

MMR status

    

<0.0001

 MMR proficient

833 (85%)

184 (95%)

485 (89%)

164 (67%)

 

 MMR deficient

150 (15%)

10 (5.2%)

60 (11%)

80 (33%)

 

BRAF status

    

<0.0001

 Wild-type

824 (84%)

177 (91%)

469 (86%)

178 (73%)

 

 Mutant

159 (16%)

17 (8.8%)

76 (14 %)

66 (27%)

 
  1. AJCC American Joint Committee on Cancer, MMR mismatch repair.